Asthma at the crossroads: From anti-TNF-α setbacks to next-generation biologics targeting type 1 and type 2 inflammation.
- DOI
- 10.1016/j.rmed.2026.109033
- Published
- 2026 Sep
- Container
- Respiratory medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.rmed.2026.109033,
title = {Asthma at the crossroads: From anti-TNF-α setbacks to next-generation biologics targeting type 1 and type 2 inflammation.},
author = {Patel V and Khera N and Singh G and Khalid Ansari MA},
year = {2026},
journal = {Respiratory medicine},
doi = {10.1016/j.rmed.2026.109033},
url = {https://doi.org/10.1016/j.rmed.2026.109033}
}RIS
TY - JOUR TI - Asthma at the crossroads: From anti-TNF-α setbacks to next-generation biologics targeting type 1 and type 2 inflammation. AU - Patel V AU - Khera N AU - Singh G AU - Khalid Ansari MA PY - 2026 JO - Respiratory medicine DO - 10.1016/j.rmed.2026.109033 UR - https://doi.org/10.1016/j.rmed.2026.109033 ER -
APA
V, P., N, K., G, S., & MA, K. A. (2026). Asthma at the crossroads: From anti-TNF-α setbacks to next-generation biologics targeting type 1 and type 2 inflammation.. Respiratory medicine. https://doi.org/10.1016/j.rmed.2026.109033
Source records
- pubmed · retrieved 2026-09-27T10:30:08.143Z